Anbio Biotechnology Class A

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Anbio Biotechnology Class A 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NNNN

Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. 

CEO
Michael Lau
CEOMichael Lau
Employees
27
Employees27
Headquarters
Frankfurt, Hessen
HeadquartersFrankfurt, Hessen
Founded
2021
Founded2021
Employees
27
Employees27

NNNN Key Statistics

Market cap
4.15B
Market cap4.15B
Price-Earnings ratio
175.21
Price-Earnings ratio175.21
Dividend yield
Dividend yield
Average volume
26.49K
Average volume26.49K
High today
High today
Low today
Low today
Open price
$28.88
Open price$28.88
Volume
0.00
Volume0.00
52 Week high
$55.65
52 Week high$55.65
52 Week low
$6.05
52 Week low$6.05

Stock Snapshot

As of today, Anbio Biotechnology Class A(NNNN) shares are valued at $28.72. The company's market cap stands at 4.15B, with a P/E ratio of 175.21.

Anbio Biotechnology Class A(NNNN) stock opened on 2026-04-15 at $28.88. The price climbed to — and dipped to —.

The Anbio Biotechnology Class A(NNNN)'s current trading volume is 0, compared to an average daily volume of 26.49K.

During the past year, Anbio Biotechnology Class A(NNNN) stock moved between $6.05 at its lowest and $55.65 at its peak.

During the past year, Anbio Biotechnology Class A(NNNN) stock moved between $6.05 at its lowest and $55.65 at its peak.

NNNN News

Benzinga 6d
Anbio Biotechnology Posts Solid FY25 Results, Diversifies Portfolio

Anbio Biotechnology (NASDAQ:NNNN) reported full-year 2025 results on Tuesday, with sales rising to $8.65 million from $8.19 million in 2024. Net income surged t...

Anbio Biotechnology Posts Solid FY25 Results, Diversifies Portfolio

People also own

Based on the portfolios of people who own NNNN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.